| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | R$50,5280 | -0,10% | R$907,03M | R$33,25K | |
BRR ProCap Financial, Inc. Common Stock | R$9,5027 | -6,53% | R$906,65M | R$4,75M | |
HUMA Humacyte, Inc. Common Stock | R$3,2708 | -0,68% | R$903,96M | R$26,24M | |
HTLM HomesToLife Ltd Ordinary Shares | R$9,8093 | -2,04% | R$902,68M | R$90,42K | |
| R$273,31 | -3,19% | R$901,59M | R$175,17K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | R$85,5247 | -0,65% | R$900,72M | R$90,02K | |
PAAC Proem Acquisition Corp I Ordinary Shares | R$50,8601 | -0,05% | R$900,05M | R$546,66 | |
BNR Burning Rock Biotech Limited American Depositary Shares | R$47,2583 | +1,20% | R$899,81M | R$9,96K | |
LFCR Lifecore Biomedical, Inc. Common Stock | R$22,5307 | -3,71% | R$898,77M | R$624,11K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | R$52,0607 | +0,00% | R$896,68M | R$51,13K | |
| R$19,2609 | -8,72% | R$896,04M | R$634,16K | |
ECBK ECB Bancorp, Inc. Common Stock | R$103,71 | +2,22% | R$894,92M | R$54,53K | |
TNXP Tonix Pharmaceuticals Holding Corp. | R$54,3598 | +0,47% | R$894,22M | R$1,92M | |
| R$46,0321 | -2,70% | R$893,53M | R$1,25M | |
DHF BNY Mellon High Yield Strategies Fund | R$12,2008 | -0,50% | R$891,86M | R$2,14M | |
